Literature DB >> 2398803

Patients may not recall disclosure of risk of death: implications for informed consent.

T C Wade.   

Abstract

This study examined the issue of rational decision-making involved in the 'patient need' standard of informed consent. A majority of elective cholecystectomy patients (90% of 144) correctly identified their risk of death on a multiple choice questionnaire after preoperative counselling, but before surgery. However, many of those patients who answered correctly (54%) reported that they were not informed about the risk of death when questioned again after discharge. An attempt to discriminate patients who reported being informed from those who did not using measures of preoperative pain, emotional distress and medication was not successful. Faced with an inability to obtain informed consent from some patients, coupled with legal liability for failing to do so, surgeons are advised to obtain consent in writing, to provide comprehensive, multi-media counselling, and to be particularly conscientious with confused patients and those with complications.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Year:  1990        PMID: 2398803     DOI: 10.1177/002580249003000315

Source DB:  PubMed          Journal:  Med Sci Law        ISSN: 0025-8024            Impact factor:   1.266


  3 in total

1.  Bioethics for clinicians: 2. Disclosure.

Authors:  E Etchells; G Sharpe; M M Burgess; P A Singer
Journal:  CMAJ       Date:  1996-08-15       Impact factor: 8.262

Review 2.  Physicians in health care management: 8. The patient-physician partnership: decision making, problem solving and the desire to participate.

Authors:  R B Deber
Journal:  CMAJ       Date:  1994-08-15       Impact factor: 8.262

3.  Long term understanding of study information in research participants with Parkinson's disease.

Authors:  Bernard Ravina; Christopher Swearingen; Jordan Elm; Cornelia Kamp; Karl Kieburtz; Scott Y H Kim
Journal:  Parkinsonism Relat Disord       Date:  2009-06-05       Impact factor: 4.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.